HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

MK 0873

Also Known As:

MK-0873; MK0873

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Naphthyridines: 2
      - MK 0873: 1

Experts

1.	Boot, J D: 1 article (01/2008)
2.	Cohen, A F: 1 article (01/2008)
3.	De Haas, S L: 1 article (01/2008)
4.	De Smet, M: 1 article (01/2008)
5.	Denker, A: 1 article (01/2008)
6.	Diamant, Z: 1 article (01/2008)
7.	Leathem, T: 1 article (01/2008)
8.	Miller, D: 1 article (01/2008)
9.	Schoemaker, R C: 1 article (01/2008)
10.	Van Doorn, M B A: 1 article (01/2008)

Related Diseases

1.	Chronic Obstructive Pulmonary Disease (COPD) 01/01/2008 - "MK-0873 is a novel selective phosphodiesterase-4 inhibitor, which has been in development for the treatment of chronic obstructive pulmonary disease (COPD). "

Related Drugs and Biologics

1.	Type 4 Cyclic Nucleotide Phosphodiesterases